AR and benign prostatic hyperplasia: These propositions entail four theories: renin-angiotensin system (RAS) dysregulation [17], the androgen-related theory postulating an exacerbation of BPH symptoms due to increased androgen receptor activity associated with elevated dydrogesterone [18], inflammation-related factors [19], and metabolic derangement associations [20].